The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anti-Neprilysin Market Research Report 2025
Synopsis
Neprilysin is a neutral endopeptidase and its inhibition increases bioavailability of natriuretic peptides, bradykinin, and substance P, resulting in natriuretic, vasodilatatory, and anti-proliferative effects.
The global Anti-Neprilysin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Anti-Neprilysin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Anti-Neprilysin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Anti-Neprilysin in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Anti-Neprilysin include Bioprojet SCR, Novartis International AG, Pharmaleads SA, Theravance Biopharma Inc., Cipla Limited and Oceanic Pharmachem Pvt. Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Anti-Neprilysin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Neprilysin.
Report Scope
The Anti-Neprilysin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Neprilysin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Neprilysin companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bioprojet SCR
Novartis International AG
Pharmaleads SA
Theravance Biopharma Inc.
Cipla Limited
Oceanic Pharmachem Pvt. Ltd
Segment by Type
Sacubitril
TD-0714
STR-324
PL-265
LHW-090
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-Neprilysin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Neprilysin is a neutral endopeptidase and its inhibition increases bioavailability of natriuretic peptides, bradykinin, and substance P, resulting in natriuretic, vasodilatatory, and anti-proliferative effects.
The global Anti-Neprilysin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Anti-Neprilysin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Anti-Neprilysin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Anti-Neprilysin in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Anti-Neprilysin include Bioprojet SCR, Novartis International AG, Pharmaleads SA, Theravance Biopharma Inc., Cipla Limited and Oceanic Pharmachem Pvt. Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Anti-Neprilysin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Neprilysin.
Report Scope
The Anti-Neprilysin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Neprilysin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Neprilysin companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bioprojet SCR
Novartis International AG
Pharmaleads SA
Theravance Biopharma Inc.
Cipla Limited
Oceanic Pharmachem Pvt. Ltd
Segment by Type
Sacubitril
TD-0714
STR-324
PL-265
LHW-090
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-Neprilysin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Neprilysin Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Sacubitril
1.2.3 TD-0714
1.2.4 STR-324
1.2.5 PL-265
1.2.6 LHW-090
1.3 Market by Application
1.3.1 Global Anti-Neprilysin Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-Neprilysin Market Perspective (2019-2030)
2.2 Anti-Neprilysin Growth Trends by Region
2.2.1 Global Anti-Neprilysin Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Anti-Neprilysin Historic Market Size by Region (2019-2024)
2.2.3 Anti-Neprilysin Forecasted Market Size by Region (2025-2030)
2.3 Anti-Neprilysin Market Dynamics
2.3.1 Anti-Neprilysin Industry Trends
2.3.2 Anti-Neprilysin Market Drivers
2.3.3 Anti-Neprilysin Market Challenges
2.3.4 Anti-Neprilysin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-Neprilysin Players by Revenue
3.1.1 Global Top Anti-Neprilysin Players by Revenue (2019-2024)
3.1.2 Global Anti-Neprilysin Revenue Market Share by Players (2019-2024)
3.2 Global Anti-Neprilysin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-Neprilysin Revenue
3.4 Global Anti-Neprilysin Market Concentration Ratio
3.4.1 Global Anti-Neprilysin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Neprilysin Revenue in 2023
3.5 Anti-Neprilysin Key Players Head office and Area Served
3.6 Key Players Anti-Neprilysin Product Solution and Service
3.7 Date of Enter into Anti-Neprilysin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Neprilysin Breakdown Data by Type
4.1 Global Anti-Neprilysin Historic Market Size by Type (2019-2024)
4.2 Global Anti-Neprilysin Forecasted Market Size by Type (2025-2030)
5 Anti-Neprilysin Breakdown Data by Application
5.1 Global Anti-Neprilysin Historic Market Size by Application (2019-2024)
5.2 Global Anti-Neprilysin Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Anti-Neprilysin Market Size (2019-2030)
6.2 North America Anti-Neprilysin Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Anti-Neprilysin Market Size by Country (2019-2024)
6.4 North America Anti-Neprilysin Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-Neprilysin Market Size (2019-2030)
7.2 Europe Anti-Neprilysin Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Anti-Neprilysin Market Size by Country (2019-2024)
7.4 Europe Anti-Neprilysin Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-Neprilysin Market Size (2019-2030)
8.2 Asia-Pacific Anti-Neprilysin Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Anti-Neprilysin Market Size by Region (2019-2024)
8.4 Asia-Pacific Anti-Neprilysin Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-Neprilysin Market Size (2019-2030)
9.2 Latin America Anti-Neprilysin Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Anti-Neprilysin Market Size by Country (2019-2024)
9.4 Latin America Anti-Neprilysin Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-Neprilysin Market Size (2019-2030)
10.2 Middle East & Africa Anti-Neprilysin Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Anti-Neprilysin Market Size by Country (2019-2024)
10.4 Middle East & Africa Anti-Neprilysin Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bioprojet SCR
11.1.1 Bioprojet SCR Company Detail
11.1.2 Bioprojet SCR Business Overview
11.1.3 Bioprojet SCR Anti-Neprilysin Introduction
11.1.4 Bioprojet SCR Revenue in Anti-Neprilysin Business (2019-2024)
11.1.5 Bioprojet SCR Recent Development
11.2 Novartis International AG
11.2.1 Novartis International AG Company Detail
11.2.2 Novartis International AG Business Overview
11.2.3 Novartis International AG Anti-Neprilysin Introduction
11.2.4 Novartis International AG Revenue in Anti-Neprilysin Business (2019-2024)
11.2.5 Novartis International AG Recent Development
11.3 Pharmaleads SA
11.3.1 Pharmaleads SA Company Detail
11.3.2 Pharmaleads SA Business Overview
11.3.3 Pharmaleads SA Anti-Neprilysin Introduction
11.3.4 Pharmaleads SA Revenue in Anti-Neprilysin Business (2019-2024)
11.3.5 Pharmaleads SA Recent Development
11.4 Theravance Biopharma Inc.
11.4.1 Theravance Biopharma Inc. Company Detail
11.4.2 Theravance Biopharma Inc. Business Overview
11.4.3 Theravance Biopharma Inc. Anti-Neprilysin Introduction
11.4.4 Theravance Biopharma Inc. Revenue in Anti-Neprilysin Business (2019-2024)
11.4.5 Theravance Biopharma Inc. Recent Development
11.5 Cipla Limited
11.5.1 Cipla Limited Company Detail
11.5.2 Cipla Limited Business Overview
11.5.3 Cipla Limited Anti-Neprilysin Introduction
11.5.4 Cipla Limited Revenue in Anti-Neprilysin Business (2019-2024)
11.5.5 Cipla Limited Recent Development
11.6 Oceanic Pharmachem Pvt. Ltd
11.6.1 Oceanic Pharmachem Pvt. Ltd Company Detail
11.6.2 Oceanic Pharmachem Pvt. Ltd Business Overview
11.6.3 Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Introduction
11.6.4 Oceanic Pharmachem Pvt. Ltd Revenue in Anti-Neprilysin Business (2019-2024)
11.6.5 Oceanic Pharmachem Pvt. Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Anti-Neprilysin Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Sacubitril
Table 3. Key Players of TD-0714
Table 4. Key Players of STR-324
Table 5. Key Players of PL-265
Table 6. Key Players of LHW-090
Table 7. Global Anti-Neprilysin Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Anti-Neprilysin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Anti-Neprilysin Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Anti-Neprilysin Market Share by Region (2019-2024)
Table 11. Global Anti-Neprilysin Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Anti-Neprilysin Market Share by Region (2025-2030)
Table 13. Anti-Neprilysin Market Trends
Table 14. Anti-Neprilysin Market Drivers
Table 15. Anti-Neprilysin Market Challenges
Table 16. Anti-Neprilysin Market Restraints
Table 17. Global Anti-Neprilysin Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Anti-Neprilysin Market Share by Players (2019-2024)
Table 19. Global Top Anti-Neprilysin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Neprilysin as of 2023)
Table 20. Ranking of Global Top Anti-Neprilysin Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Anti-Neprilysin Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Anti-Neprilysin Product Solution and Service
Table 24. Date of Enter into Anti-Neprilysin Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Anti-Neprilysin Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Anti-Neprilysin Revenue Market Share by Type (2019-2024)
Table 28. Global Anti-Neprilysin Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Anti-Neprilysin Revenue Market Share by Type (2025-2030)
Table 30. Global Anti-Neprilysin Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Anti-Neprilysin Revenue Market Share by Application (2019-2024)
Table 32. Global Anti-Neprilysin Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Anti-Neprilysin Revenue Market Share by Application (2025-2030)
Table 34. North America Anti-Neprilysin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Anti-Neprilysin Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Anti-Neprilysin Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Anti-Neprilysin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Anti-Neprilysin Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Anti-Neprilysin Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Anti-Neprilysin Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Anti-Neprilysin Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Anti-Neprilysin Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Anti-Neprilysin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Anti-Neprilysin Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Anti-Neprilysin Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Anti-Neprilysin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Anti-Neprilysin Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Anti-Neprilysin Market Size by Country (2025-2030) & (US$ Million)
Table 49. Bioprojet SCR Company Detail
Table 50. Bioprojet SCR Business Overview
Table 51. Bioprojet SCR Anti-Neprilysin Product
Table 52. Bioprojet SCR Revenue in Anti-Neprilysin Business (2019-2024) & (US$ Million)
Table 53. Bioprojet SCR Recent Development
Table 54. Novartis International AG Company Detail
Table 55. Novartis International AG Business Overview
Table 56. Novartis International AG Anti-Neprilysin Product
Table 57. Novartis International AG Revenue in Anti-Neprilysin Business (2019-2024) & (US$ Million)
Table 58. Novartis International AG Recent Development
Table 59. Pharmaleads SA Company Detail
Table 60. Pharmaleads SA Business Overview
Table 61. Pharmaleads SA Anti-Neprilysin Product
Table 62. Pharmaleads SA Revenue in Anti-Neprilysin Business (2019-2024) & (US$ Million)
Table 63. Pharmaleads SA Recent Development
Table 64. Theravance Biopharma Inc. Company Detail
Table 65. Theravance Biopharma Inc. Business Overview
Table 66. Theravance Biopharma Inc. Anti-Neprilysin Product
Table 67. Theravance Biopharma Inc. Revenue in Anti-Neprilysin Business (2019-2024) & (US$ Million)
Table 68. Theravance Biopharma Inc. Recent Development
Table 69. Cipla Limited Company Detail
Table 70. Cipla Limited Business Overview
Table 71. Cipla Limited Anti-Neprilysin Product
Table 72. Cipla Limited Revenue in Anti-Neprilysin Business (2019-2024) & (US$ Million)
Table 73. Cipla Limited Recent Development
Table 74. Oceanic Pharmachem Pvt. Ltd Company Detail
Table 75. Oceanic Pharmachem Pvt. Ltd Business Overview
Table 76. Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Product
Table 77. Oceanic Pharmachem Pvt. Ltd Revenue in Anti-Neprilysin Business (2019-2024) & (US$ Million)
Table 78. Oceanic Pharmachem Pvt. Ltd Recent Development
Table 79. Research Programs/Design for This Report
Table 80. Key Data Information from Secondary Sources
Table 81. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Neprilysin Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Anti-Neprilysin Market Share by Type: 2023 VS 2030
Figure 3. Sacubitril Features
Figure 4. TD-0714 Features
Figure 5. STR-324 Features
Figure 6. PL-265 Features
Figure 7. LHW-090 Features
Figure 8. Global Anti-Neprilysin Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Anti-Neprilysin Market Share by Application: 2023 VS 2030
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Anti-Neprilysin Report Years Considered
Figure 14. Global Anti-Neprilysin Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Anti-Neprilysin Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Anti-Neprilysin Market Share by Region: 2023 VS 2030
Figure 17. Global Anti-Neprilysin Market Share by Players in 2023
Figure 18. Global Top Anti-Neprilysin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Neprilysin as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Anti-Neprilysin Revenue in 2023
Figure 20. North America Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Anti-Neprilysin Market Share by Country (2019-2030)
Figure 22. United States Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Anti-Neprilysin Market Share by Country (2019-2030)
Figure 26. Germany Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Anti-Neprilysin Market Share by Region (2019-2030)
Figure 34. China Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Anti-Neprilysin Market Share by Country (2019-2030)
Figure 42. Mexico Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Anti-Neprilysin Market Share by Country (2019-2030)
Figure 46. Turkey Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Anti-Neprilysin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Bioprojet SCR Revenue Growth Rate in Anti-Neprilysin Business (2019-2024)
Figure 49. Novartis International AG Revenue Growth Rate in Anti-Neprilysin Business (2019-2024)
Figure 50. Pharmaleads SA Revenue Growth Rate in Anti-Neprilysin Business (2019-2024)
Figure 51. Theravance Biopharma Inc. Revenue Growth Rate in Anti-Neprilysin Business (2019-2024)
Figure 52. Cipla Limited Revenue Growth Rate in Anti-Neprilysin Business (2019-2024)
Figure 53. Oceanic Pharmachem Pvt. Ltd Revenue Growth Rate in Anti-Neprilysin Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
